120 related articles for article (PubMed ID: 9448585)
1. Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis.
Larsson E; Müssener A; Heinegård D; Klareskog L; Saxne T
Br J Rheumatol; 1997 Dec; 36(12):1258-61. PubMed ID: 9448585
[TBL] [Abstract][Full Text] [Related]
2. Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism.
Månsson B; Carey D; Alini M; Ionescu M; Rosenberg LC; Poole AR; Heinegård D; Saxne T
J Clin Invest; 1995 Mar; 95(3):1071-7. PubMed ID: 7533784
[TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats.
Vingsbo-Lundberg C; Saxne T; Olsson H; Holmdahl R
Arthritis Rheum; 1998 Mar; 41(3):544-50. PubMed ID: 9506583
[TBL] [Abstract][Full Text] [Related]
4. Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis.
Mânsson B; Gülfe A; Geborek P; Heinegård D; Saxne T
Ann Rheum Dis; 2001 Jan; 60(1):27-31. PubMed ID: 11114278
[TBL] [Abstract][Full Text] [Related]
5. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
6. Tissue-derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: relationship to development of joint destruction in hands and feet.
Fex E; Eberhardt K; Saxne T
Br J Rheumatol; 1997 Nov; 36(11):1161-5. PubMed ID: 9402859
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study.
Conrozier T; Saxne T; Fan CS; Mathieu P; Tron AM; Heinegård D; Vignon E
Ann Rheum Dis; 1998 Sep; 57(9):527-32. PubMed ID: 9849311
[TBL] [Abstract][Full Text] [Related]
8. Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritis.
Petersson IF; Boegård T; Dahlström J; Svensson B; Heinegård D; Saxne T
Osteoarthritis Cartilage; 1998 Jan; 6(1):33-9. PubMed ID: 9616437
[TBL] [Abstract][Full Text] [Related]
9. Cartilage and bone macromolecules in knee joint synovial fluid in rheumatoid arthritis: relation to development of knee or hip joint destruction.
Månsson B; Geborek P; Saxne T
Ann Rheum Dis; 1997 Feb; 56(2):91-6. PubMed ID: 9068280
[TBL] [Abstract][Full Text] [Related]
10. Distribution and expression of cartilage oligomeric matrix protein and bone sialoprotein show marked changes during rat femoral head development.
Shen Z; Heinegård D; Sommarin Y
Matrix Biol; 1995 Dec; 14(9):773-81. PubMed ID: 8785592
[TBL] [Abstract][Full Text] [Related]
11. Increased serum cartilage oligomeric matrix protein levels and decreased patellar bone mineral density in patients with chondromalacia patellae.
Murphy E; FitzGerald O; Saxne T; Bresnihan B
Ann Rheum Dis; 2002 Nov; 61(11):981-5. PubMed ID: 12379520
[TBL] [Abstract][Full Text] [Related]
12. Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint.
Petersson IF; Boegård T; Svensson B; Heinegård D; Saxne T
Br J Rheumatol; 1998 Jan; 37(1):46-50. PubMed ID: 9487250
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats.
Larsson E; Erlandsson Harris H; Lorentzen JC; Larsson A; Månsson B; Klareskog L; Saxne T
Rheumatology (Oxford); 2002 Sep; 41(9):996-1000. PubMed ID: 12209032
[TBL] [Abstract][Full Text] [Related]
14. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP.
Larsson E; Erlandsson Harris H; Larsson A; Månsson B; Saxne T; Klareskog L
Rheumatology (Oxford); 2004 Apr; 43(4):428-34. PubMed ID: 15024132
[TBL] [Abstract][Full Text] [Related]
16. Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats.
Carlsén S; Hansson AS; Olsson H; Heinegård D; Holmdahl R
Clin Exp Immunol; 1998 Dec; 114(3):477-84. PubMed ID: 9844060
[TBL] [Abstract][Full Text] [Related]
17. Cartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritis.
Geng H; Carlsen S; Nandakumar KS; Holmdahl R; Aspberg A; Oldberg A; Mattsson R
Arthritis Res Ther; 2008; 10(6):R134. PubMed ID: 19014566
[TBL] [Abstract][Full Text] [Related]
18. Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year study.
Roux-Lombard P; Eberhardt K; Saxne T; Dayer JM; Wollheim FA
Rheumatology (Oxford); 2001 May; 40(5):544-51. PubMed ID: 11371663
[TBL] [Abstract][Full Text] [Related]
19. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation.
Neidhart M; Hauser N; Paulsson M; DiCesare PE; Michel BA; Häuselmann HJ
Br J Rheumatol; 1997 Nov; 36(11):1151-60. PubMed ID: 9402858
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of cartilage destruction in collagen-induced arthritis by altered CII 263-272 peptide: experiment with rats].
Yao ZQ; Zhao JX; Li R; Li ZG
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3055-8. PubMed ID: 17288836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
